Skip to main content
. 2015 Apr 28;1(1):e000044. doi: 10.1136/rmdopen-2014-000044

Figure 5.

Figure 5

PPD status of CZP-treated patients with RA in the pooled RA safety database (N=4049) at baseline and TB incidence by INH treatment. †One patient who developed TB started INH treatment 393 days after the first CZP dose was administered. INH was administered from 517 to 251 days before TB was diagnosed. CZP, certolizumab pegol; PPD, purified protein derivative; INH, isoniazid; RA, rheumatoid arthritis; TB, tuberculosis.